Represented China SXT Pharmaceuticals, Inc. in $10 Million Registered Direct Offering

Represented China SXT Pharmaceuticals, Inc., an innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, in its $10 million registered direct offering.